Zhang Peng, Hölscher Christian, Ma Xun
Rev Neurosci. 2017 Jan 1;28(1):87-101. doi: 10.1515/revneuro-2016-0053.
Spinal cord injury (SCI) is a catastrophic event that can profoundly affect a patient's life, with far-reaching social and economic effects. A consequential sequence of SCI is the significant neurological or psychological deficit, which obviously contributes to the overall burden of this condition. To date, there is no effective treatment for SCI. Therefore, developing novel therapeutic strategies for SCI is highly prioritized. Flavonoids, one of the most numerous and ubiquitous groups of plant metabolites, are the active ingredients of traditional Chinese medicine such as Scutellaria baicalensis Georgi (Huang Qin) or Ginkgo biloba (Ying Xin). Accumulated research data show that flavonoids possess a range of key pharmacological properties such as anti-inflammatory, anti-oxidant, anti-tumor, anti-viral, anti-cardiovascular disease, immunomodulatory, and neuroprotective effects. Based on this, the flavonoids show therapeutic potential for SCI diseases. In this paper, we will review the pharmacological properties of different types of flavonoids for the treatment of SCI diseases, and potential underlying biochemical mechanisms of action will also be described.
脊髓损伤(SCI)是一种灾难性事件,会对患者的生活产生深远影响,并带来广泛的社会和经济影响。SCI的一个必然结果是严重的神经或心理缺陷,这显然加重了这种疾病的整体负担。迄今为止,尚无针对SCI的有效治疗方法。因此,开发针对SCI的新型治疗策略具有高度优先性。黄酮类化合物是植物代谢产物中数量最多、分布最广的一类,是传统中药如黄芩(Huang Qin)或银杏(Ying Xin)的活性成分。积累的研究数据表明,黄酮类化合物具有一系列关键药理特性,如抗炎、抗氧化、抗肿瘤、抗病毒、抗心血管疾病、免疫调节和神经保护作用。基于此,黄酮类化合物显示出治疗SCI疾病的潜力。在本文中,我们将综述不同类型黄酮类化合物治疗SCI疾病的药理特性,并描述潜在的生化作用机制。